EUR 13.5
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 19.98 Million EUR | 12.91% |
2022 | 26.49 Million EUR | -39.36% |
2021 | 43.68 Million EUR | 1.92% |
2020 | 42.86 Million EUR | -11.53% |
2019 | 48.44 Million EUR | 236.08% |
2018 | 14.41 Million EUR | -22.27% |
2017 | 18.54 Million EUR | 529.14% |
2016 | 2.94 Million EUR | -92.88% |
2015 | 41.4 Million EUR | 7.57% |
2014 | 38.48 Million EUR | 50.39% |
2013 | 25.59 Million EUR | 173.61% |
2012 | -34.76 Million EUR | -145.79% |
2011 | 75.92 Million EUR | 1099.76% |
2010 | -7.59 Million EUR | -107.61% |
2009 | 99.83 Million EUR | 10.73% |
2008 | 90.15 Million EUR | 0.3% |
2007 | 89.88 Million EUR | 35.78% |
2006 | 66.19 Million EUR | 314.54% |
2005 | 15.96 Million EUR | -70.81% |
2004 | 54.7 Million EUR | 18.0% |
2003 | 46.36 Million EUR | 24.31% |
2002 | 37.29 Million EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 3.85 Million EUR | -27.65% |
2024 Q2 | 3.85 Million EUR | 0.0% |
2023 FY | 29.91 Million EUR | 12.91% |
2023 Q4 | 5.33 Million EUR | -45.81% |
2023 Q2 | 5.07 Million EUR | 0.0% |
2023 Q1 | 5.07 Million EUR | -42.94% |
2023 Q3 | 9.84 Million EUR | 93.78% |
2022 Q3 | 8.9 Million EUR | 72.0% |
2022 Q1 | 2.64 Million EUR | -89.55% |
2022 Q4 | 8.9 Million EUR | 0.0% |
2022 Q2 | 5.17 Million EUR | 95.51% |
2022 FY | 26.49 Million EUR | -39.36% |
2021 FY | 43.68 Million EUR | 1.92% |
2021 Q1 | 5.19 Million EUR | -84.86% |
2021 Q2 | 10.56 Million EUR | 103.47% |
2021 Q4 | 25.34 Million EUR | 93.11% |
2021 Q3 | 13.12 Million EUR | 24.17% |
2020 Q3 | 20.09 Million EUR | 346.46% |
2020 Q2 | 4.5 Million EUR | 96.38% |
2020 FY | 42.86 Million EUR | -11.53% |
2020 Q1 | 2.29 Million EUR | -90.22% |
2020 Q4 | 34.29 Million EUR | 70.65% |
2019 Q4 | 23.44 Million EUR | 98.43% |
2019 Q2 | 5.51 Million EUR | 0.0% |
2019 Q1 | 5.51 Million EUR | -45.65% |
2019 FY | 48.44 Million EUR | 236.08% |
2019 Q3 | 11.81 Million EUR | 114.17% |
2018 FY | 14.41 Million EUR | -22.27% |
2018 Q1 | 5.31 Million EUR | -59.71% |
2018 Q2 | 5.31 Million EUR | 0.0% |
2018 Q3 | 10.14 Million EUR | 90.96% |
2018 Q4 | 10.14 Million EUR | 0.0% |
2017 Q1 | 4.37 Million EUR | -67.22% |
2017 Q4 | 13.19 Million EUR | 0.0% |
2017 Q3 | 13.19 Million EUR | 201.61% |
2017 FY | 18.54 Million EUR | 529.14% |
2017 Q2 | 4.37 Million EUR | 0.0% |
2016 Q2 | 13.1 Million EUR | 236.64% |
2016 Q1 | 3.89 Million EUR | -78.57% |
2016 Q3 | 6.38 Million EUR | -51.26% |
2016 Q4 | 13.34 Million EUR | 108.91% |
2016 FY | 2.94 Million EUR | -92.88% |
2015 Q2 | 9.66 Million EUR | 80.8% |
2015 FY | 41.4 Million EUR | 7.57% |
2015 Q4 | 18.16 Million EUR | 120.61% |
2015 Q3 | 8.23 Million EUR | -14.79% |
2015 Q1 | 5.34 Million EUR | -35.72% |
2014 FY | 38.48 Million EUR | 50.39% |
2014 Q4 | 8.31 Million EUR | -54.3% |
2014 Q3 | 18.19 Million EUR | 65.98% |
2014 Q2 | 10.96 Million EUR | 969.27% |
2014 Q1 | 1.02 Million EUR | 107.1% |
2013 Q2 | 20.24 Million EUR | 1121.73% |
2013 Q3 | 18.12 Million EUR | -10.45% |
2013 Q4 | -14.43 Million EUR | -179.64% |
2013 FY | 25.59 Million EUR | 173.61% |
2013 Q1 | 1.65 Million EUR | -96.12% |
2012 Q4 | 42.72 Million EUR | 2095.27% |
2012 Q1 | -1.51 Million EUR | 0.0% |
2012 Q2 | -77.92 Million EUR | -5056.92% |
2012 Q3 | 1.94 Million EUR | 102.5% |
2012 FY | -34.76 Million EUR | -145.79% |
2011 FY | 75.92 Million EUR | 1099.76% |
2010 FY | -7.59 Million EUR | -107.61% |
2009 FY | 99.83 Million EUR | 10.73% |
2008 FY | 90.15 Million EUR | 0.3% |
2007 FY | 89.88 Million EUR | 35.78% |
2006 FY | 66.19 Million EUR | 314.54% |
2005 FY | 15.96 Million EUR | -70.81% |
2004 FY | 54.7 Million EUR | 18.0% |
2003 FY | 46.36 Million EUR | 24.31% |
2002 FY | 37.29 Million EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Guerbet SA | 38.67 Million EUR | 48.326% |
Nexus AG | 24.76 Million EUR | 19.313% |
Bastide Le Confort Médical SA | 44.22 Million EUR | 54.812% |
Revenio Group Oyj | 26.34 Million EUR | 24.143% |
Drägerwerk AG & Co. KGaA | 171.18 Million EUR | 88.326% |
Sartorius Aktiengesellschaft | 541 Million EUR | 96.306% |
LNA Santé SA | 62.98 Million EUR | 68.271% |
Siemens Healthineers AG | 2.86 Billion EUR | 99.303% |
Medios AG | 31.37 Million EUR | 36.301% |
Equasens Société anonyme | 55.2 Million EUR | 63.804% |
Stratec SE | 22.88 Million EUR | 12.692% |